1.
Ibrahim EM, Refae AA, Bayer AM, Abdullah N, Al-Foheidi ME. Adjuvant Therapy Benefits for Patients With Human Epidermal Growth Factor Receptor 2-Positive T1aN0M0 Breast Cancer: A Systematic Review and Meta-Analysis. World J Oncol [Internet]. 2025 Jun. 14 [cited 2025 Jun. 18];16(3):276-85. Available from: https://wjon.elmerpub.com/wjon/article/view/2578